Mangoceuticals, Inc. (NASDAQ: MGRX) announced on February 20, 2025, the official launch of PeachesRx, an innovative women's health and wellness brand. This new brand is focused on providing cutting-edge, convenient treatments tailored to women's unique health needs.
PeachesRx will offer personalized wellness solutions, including a focus on GLP-1 weight loss treatments. This expansion marks a significant strategic move for Mangoceuticals, extending its telemedicine platform beyond its established MangoRx men's health brand.
The launch into the women's telehealth market, particularly with GLP-1 treatments, positions Mangoceuticals to address a growing and high-demand segment of the healthcare industry. This initiative aims to capture new customer demographics and diversify revenue streams.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.